Clinical Trial Update: A Study of the Effects of Desloratadine on Conjunctival Allergen Challenge-induced Ocular Signs and Symptoms (Study P04209) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the effects of desloratadine on ocular signs and symptoms after conjunctival allergen challenge in allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Conjunctivitis, Allergic | Phase 4 | Status: COMPLETED